sup 4 from Personalized RNA Medicine for Pancreatic Cancer

Authors :: Frank J. Slack
Sangeeta N. Bhatia
Manuel Hidalgo
Senthil K. Muthuswamy
Jong Cheol Jeong
Emilia Pulver
Pedro P. Lopez-Casas
Rajesha Rupaimoole
Ling Huang
Liangliang Hao
Maud-Emmanuelle Gilles
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplemental Figure 4. A) qPCR analysis of miR-21-5p expression level after 4 treatments with TPN-21 in PDO 286. B) Relative tumor burden after (4 I.V injection of PBS (n=6) TPN-control n=6 or TPN-21 n=5 (5mg/kg). For qPCR each miRNA sample was normalized on the basis of its 18s content.